Table 2

Pharmacokinetic parameters for the disposition of GG in the rat isolated perfused liver in the absence (control) and presence of acetaminophen (A), acetaminophen glucuronide (AG), and clofibric acid (CFA)

ParameterControlAAGCFA
CL (ml/min)10.4  ± 1.411.3  ± 1.712.2  ± 2.714.8  ± 1.72-150
t 1/2 (min)22.5  ± 4.422.3  ± 8.018.5  ± 3.317.0  ± 2.0
E0.346  ± 0.0460.376  ± 0.0560.407  ± 0.0880.493  ± 0.0562-150
CLint,app (ml/min)94.1  ± 17.9126.1  ± 31.8144.4  ± 60.3187.0  ± 40.72-150
t 1/2,bile (min)30.9  ± 4.928.1  ± 4.829.1  ± 10.221.1  ± 2.32-150
BGG (% Dose)72.8  ± 10.974.5  ± 15.668.9  ± 9.974.5  ± 9.8
[GG]LIVER (nmol/g tissue)3.40  ± 0.642.57  ± 1.012.95  ± 1.291.82  ± 0.142-150
[GG]LIVER/PERFUSATE 35.0  ± 22.526.6  ± 26.046.8  ± 21.249.4  ± 19.22-a
[GG]LIVER/PERFUSATE(unb) 204.6  ± 131.5237.5  ± 155.8311.4  ± 140.9310.2  ± 120.6
[GG]BILE/LIVER 89.6  ± 17.6108.8  ± 24.3101.1  ± 24.185.6  ± 26.9
  • [GG]LIVER, intrahepatic concentration of GG at 90 min; [GG]LIVER/PERFUSATE and [GG]LIVER/PERFUSATE(unb), liver to total perfusate and unbound perfusate concentration ratios, respectively, of GG; [GG]BILE/LIVER, bile to liver concentration ratio of GG.

  • 2-a  Perfusate GG concentrations at 90 min were extrapolated from the last measured concentration multiplied by e(−kt), where k is the elimination rate constant and t is the time difference between the last measured concentration and the end of the perfusion.

  • 2-150P < .05 compared with the control value.